Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

After The Bloodbath, Where Does Pharmacyclics Go From Here?
Seeking Alpha
Thursday, November 15, 2012 - 11:58am
tags:
Pharmacyclics, earnings
MAP Pharma's Awkward FDA Silence
TheStreet.com
Thursday, November 15, 2012 - 11:57am
tags:
FDA, MAP Pharmaceuticals, migraines, Levadex
Upstart Valor launches with plans to develop armed antibody cancer drugs
Fierce Biotech
Thursday, November 15, 2012 - 11:35am
tags:
Valor, armed-antibodies, cancer
Tranzyme Stomach Paralysis Drug Comes Up Short
TheStreet.com
Thursday, November 15, 2012 - 11:33am
tags:
stomach paralysis, Tranzyme
Alnylam: No Approved Drugs, No Promising Candidates, No Justification For $1 Billion Valuation
Seeking Alpha
Thursday, November 15, 2012 - 11:32am
tags:
Alnylam
J&J, Lilly, Merck plan clinical trial site database
Reuters
Thursday, November 15, 2012 - 11:13am
tags:
JNJ, Eli Lilly, Merck, clinical trials
Gilead's single tablet Stribild shows positive results in two HIV studies
Yahoo/Fly on the Wall
Thursday, November 15, 2012 - 11:11am
tags:
HIV, Stribild, Gilead
Merck KGaA expects to publish Stimuvax data in Q1 2013
Reuters
Thursday, November 15, 2012 - 11:09am
tags:
Merck KGaA, Stimuvax, vaccines, cancer, Oncothyreon
Incyte Achieves $50 Million Milestone as Oral JAK1/JAK2 Inhibitor Baricitinib Advances into Phase III Development for Rheumatoid Arthritis
Yahoo
Thursday, November 15, 2012 - 11:06am
tags:
baricitinib, Incyte, JAK inhibitors, Eli Lilly, rheumatoid arthritis
The Other Side Of Galena Biopharma
Seeking Alpha
Thursday, November 15, 2012 - 11:06am
tags:
Galena Biopharma
GlaxoSmithKline says FDA panel recommends approval of H5N1 flu vaccine
The Fly on the Wall
Thursday, November 15, 2012 - 10:57am
tags:
FDA, advisory panels, H5N1, vaccines, GSK
Glaxo-Pfizer HIV Drug Helps Hard-to-Treat Patients
Bloomberg
Thursday, November 15, 2012 - 10:53am
tags:
GSK, Pfizer, HIV, Dolutegravir, Shionogi
How To Reach Those Hard-To-Reach Docs
Pharmalot
Thursday, November 15, 2012 - 10:50am
tags:
physicians, drug reps
Merck - How To Play This 'Patent Cliff' With Options
Seeking Alpha
Thursday, November 15, 2012 - 10:49am
tags:
patent cliff, Merck, Singulair, Odanacatib, Maxalt, MK-3475
Teva Is Still Healthier Than Its Big Pharma Peers
Seeking Alpha
Thursday, November 15, 2012 - 10:47am
tags:
Teva, AstraZeneca, Bristol-Myers Squibb, GSK, JNJ, Merck, Novo Nordisk, Novartis, Pfizer, Sanofi
Bristol-Myers, AstraZeneca Type 2 diabetes pill gets first major approval, in European Union
Yahoo/AP
Thursday, November 15, 2012 - 10:46am
tags:
diabetes, Bristol-Myers Squibb, AstraZeneca, Europe, SGLT2 inhibitor, Forxiga
Who Will Pioneer the New Diabetes Market?
Motley Fool
Thursday, November 15, 2012 - 10:45am
tags:
diabetes, JNJ, Merck, Bristol-Myers Squibb, AstraZeneca, SGLT2 inhibitor
3 Potential Partners for Amarin
Motley Fool
Thursday, November 15, 2012 - 10:43am
tags:
M&A, Amarin, AstraZeneca, Merck, Eli Lilly
Genzyme resolves shortage of cancer drug Thyrogen
Fierce Pharma
Wednesday, November 14, 2012 - 12:38pm
tags:
Thyrogen, Genzyme, thyroid cancer
The Stem Cell Sector Further Validates Itself With A Successful Q3
Seeking Alpha
Wednesday, November 14, 2012 - 12:37pm
tags:
stem cells, Osiris, NeoStem, Neuralstem, Aastrom Biosciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.